The scans performed at later stages of the experiment revealed the presence of a progressive infection in the controls, the partial effectiveness of the ME regimen and a greater effectiveness of the ME+D1MT treatment [36], suggesting that IDO inhibition is a viable adjunctive HDT strategy for TB. This evidence concerns the gene IDO1 and infection.